$DNLI
Denali Therapeutics Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$19.91
▼-0.45%-$0.090
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateDenali Therapeutics Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is DNLI down today? It is at $19.91 (-0.45%), and our scanner flagged it 96 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DNLI spikes, and full due diligence on DNLI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $DNLI 96 times in the last 30 days. Create a free account to track $DNLI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
DNLI is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 6 unusual-volume and momentum alerts on DNLI today, peaking at 5.1x its normal volume.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Chin Peter Scott Officer | Sold (automatic/other) | -2K | sold 0.8% | 205K | $37K at $22.29 | Sep 4, 26 |
Thornberry Nancy Director | Sold (automatic/other) | -11K | sold 37% | 20K | $261K at $22.85 | Sep 2, 26 |
Schuth Alexander O. Officer | Sold (automatic/other) | -3K | sold 1.0% | 279K | $65K at $23.44 | Sep 1, 26 |
Watts Ryan J. Officer | Sold (automatic/other) | -32K 0.02% of company | sold 1.5% | 2.12M | n/a | Aug 12, 26 |
Schuth Alexander O. Officer | Sold (automatic/other) | -3K | sold 1.0% | 282K | $72K at $25.07 | Aug 11, 26 |
Baker Bros. Advisors Lp Director | Acquired (grant/award) | +13K | added 0.3% | 3.77M | n/a | Jun 3, 26 |
Cook Jennifer E. Director | Acquired (grant/award) | +6K | added 25% | 32K | n/a | Jun 3, 26 |
Van Hauwermeiren Timothy Director | Acquired (grant/award) | +6K | added 60% | 17K | n/a | Jun 3, 26 |
Thornberry Nancy Director | Acquired (grant/award) | +6K | added 26% | 31K | n/a | Jun 3, 26 |
Schenkein David P Director | Acquired (grant/award) | +6K | added 42% | 22K | n/a | Jun 3, 26 |
Krognes Steve E. Director | Acquired (grant/award) | +6K | added 20% | 38K | n/a | Jun 3, 26 |
Klein Peter S Director | Acquired (grant/award) | +6K | added 23% | 34K | n/a | Jun 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
DNLI is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 6 unusual-volume and momentum alerts on DNLI today, peaking at 5.1x its normal volume.
DNLI last traded at $19.91, down 0.45% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Denali Therapeutics Inc. Common Stock (DNLI) is next expected to report earnings on Thursday, November 5, 2026, about 31 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The DNLI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DNLI 96 times in the last 30 days.
DNLI (Denali Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $3.20B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DNLI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$DNLI discussion
Sign in to ask a question or join the discussion.